What Is a Peptide? A First-Principles Guide to Research Peptides

The short version

A peptide is a short chain of amino acids strung together by chemical links called peptide bonds — the same kind of link that makes up every protein in the body, just far fewer of them. Where a protein might have hundreds of amino acids folded into a complex shape, a peptide is usually shorter: anywhere from two or three amino acids up to around 50. That size difference matters. Short chains move through the body differently than proteins do, they're broken down differently, and scientists can chemically engineer them in ways that are far harder with a full protein.

This site is a reading desk for four peptides that, taken together, show what that range looks like in practice: BPC-157 (15 amino acids, studied for tissue repair), GHK-Cu (a 3-amino-acid chain bound to copper, studied for skin), KPV (also 3 amino acids, studied for inflammation), and semaglutide (31 amino acids, an approved medicine for diabetes and weight management). Nothing here is medical advice, and nothing recommends a dose for any person — it explains what the published research says, with a citation behind every number.

What a peptide actually is — bonds, chains and biology from first principles

Every peptide bond forms the same way: the carboxyl group (-COOH) of one amino acid reacts with the amino group (-NH2) of the next, releasing a water molecule and leaving a rigid, planar link called an amide bond. String enough of these together and you get a peptide backbone — a repeating pattern of the same bond, amino acid after amino acid, with each amino acid's unique side chain hanging off to the side.

What separates the four peptides on this site is what happens around that basic bond. BPC-157's 15-amino-acid sequence is drawn from a partial fragment of a human gastric-juice protein, and its research is largely about what a short fragment of a larger protein can still do on its own. GHK-Cu and KPV are both just 3 amino acids long — short enough that GHK-Cu can chemically bind (chelate) a copper ion inside its own three-link chain, and short enough that KPV is itself a fragment cut from the tail end of a much larger hormone, alpha-melanocyte-stimulating hormone. Semaglutide shows the opposite move: it starts from a natural hormone (GLP-1) and re-engineers specific spots in the chain, plus adds a fatty side-chain, so it survives in the bloodstream far longer than the natural hormone does. Same bond chemistry, four very different design stories.

What are research peptides?

"Research peptide" is a supplier-industry term, not a scientific classification. It describes a peptide sold in a laboratory-grade form — usually a freeze-dried powder — labeled 'for research use only, not for human consumption.' It says nothing about whether that peptide has been through clinical trials, has regulatory approval, or has any established human dose.

Of the four peptides on this site, only semaglutide has cleared that bar: it's an FDA-approved prescription medicine with a large clinical trial program behind it. BPC-157, GHK-Cu (in its injectable/systemic form; the topical cosmetic form has a longer safety record) and KPV are, as of this writing, unapproved for human use, sold only as laboratory research chemicals, and studied mostly or entirely in animals and cell cultures rather than in controlled human trials. That distinction — approved medicine versus unapproved research chemical — is one of the clearest examples of what the word "peptide" does and doesn't tell you on its own, and it recurs across every page on this site.

Four peptides, four lessons

The four pages that follow aren't a ranked list — they're four separate case studies in peptide biology, chosen because each illustrates something different about how a short amino acid chain gets discovered, modified, and studied. Read them in any order, or start with the short version on each page for a plain-English summary before the technical detail. When you're ready to see all four side by side, compare these peptides directly.